Search results for: 'Preferred Destination for Clinical Trials Asia'
- Did you mean
- preferred desalination for clinical trials asia
- preferred destination for clinical trials a9aa
- Related search terms
- Asia Pacific Machine Tool Market - Growth Opportunities, Analysis, Forecast, Asia Pacific,2023
- forces managed security services market study
- asia managed security services market forecast to 2024
- asia pacific managed security services market forecast to 2023
- asia pacific managed security services market forecast to 2024
-
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00 -
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
25 Mar 2026  |  Global  |  Market Research
Global Clinical Diagnostics Industry Growth Opportunities, 2026–2031
Next-Gen AI-Integrated Biomarkers and Smart Automation are Advancing Precision and Early Detection in Molecular and Point-of-Care Diagnostics
The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...
$4,950.00 -
22 Apr 2026  |  Global  |  Market Research
Top 5 Key Takeaways from the Scope Summit, 2026
AI Adoption in Clinical Research has Moved from Exploration to Execution
The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...
$2,450.00 -
17 Apr 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced Biologic Therapies, AI-powered Diagnostics, Drug Delivery Platforms, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...
$950.00 -
06 Nov 2025  |  Global  |  Market Research
Global Genetic Testing Industry, Forecast of 2025–2030
Population Screening Initiatives, Reproductive Health Demand, and Clinical Risk Stratification are Accelerating Growth in Genetic Testing, Enabled by Advancements in Sequencing Technologies and Data-Driven Interpretation
This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...
$4,950.00 -
21 Jul 2026  |  Global  |  Market Research
Point-of-Care Testing Market, Global, 2024–2031
The POCT Market is Experiencing Transformational Growth, Driven by Decentralized Molecular Diagnostics, Ultra-rapid Testing, and Connected Clinical Intelligence Ecosystems
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...
$2,450.00 -
31 Jul 2025  |  Global  |  Technology Research
Growth Opportunities in RNA Therapeutics
Broad Applications Drive Growth in RNA Therapeutics
The report analyzes clinical trial activity across RNA therapeutic classes, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASO), aptamers, micro RNA (miRNA), self-amplifying RNA (saRNA), small-activating RNA (RNAa), and circular RNA (cirRNA). It highlights key players in each segment and their role in adv...
$4,950.00 -
07 Aug 2026  |  Global  |  Customer Research
Laboratory Product Purchasing Trends, United States and Europe, 2025–2026
An End-User Perspective on Spending and Growth Opportunities
Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The survey provides companies with actionable trend insigh...
$4,950.00 -
22 Sep 2025  |  Global  |  Technology Research
Growth Opportunities in Weight Management Technologies
Emerging Innovations Driving Personalized and Effective Obesity Solutions
This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...
$4,950.00